They have emerged as a promising treatment option for NAFLD due to their ability to aid in weight loss, improve insulin sensitivity, and reduce liver fat content
"After 12 weeks of treatment, we were able to reduce virtually all RLS symptoms in 63 percent of the patients," Dr
2
Talk to help reduce your chance of dehydration if symptoms worsen
"Research recently published by University College London estimates that 1.6 million adults in England, Wales and Scotland used GLP-1s, such as semaglutide (Wegovy, Ozempic) and tirzepatide (Mounjaro), between early 2024 and early 2025, to lose weight
Commonly reported side effects of BPC 157 are minimal but may include: Mild nausea or dizziness Redness or soreness at the injection site Headaches in some cases These symptoms are usually temporary and resolve quickly